Clinical Trial Update: A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease

View source ↗

Summary

This report covers a completed study evaluating infliximab in Chinese children with Crohn's disease. The sponsorship is Johnson & Johnson (China) Investment Ltd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Johnson & Johnson (China) Investment Ltd. | Conditions: Crohn Disease | Status: COMPLETED